72579-121-01 : NDC 2026 Code

72579-121-01 : Tislelizumab-jsgr ( Tevimbra )

Additionally :

You can get information about “72579-121-01” NDC code in 72579-121-01 in HTML format

HTML | 72579-121-01 in TXT (Plain Text) format

TXT | 72579-121-01 in PDF (Portable Document Format)

PDF | 72579-121-01 in XML format

XML formats.

NDC Code : 72579-121-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "72579-121-01",
    "PackageDescription": "1 VIAL, GLASS in 1 CARTON (72579-121-01)  / 10 mL in 1 VIAL, GLASS",
    "NDC11Code": "72579-0121-01",
    "ProductNDC": "72579-121",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Tevimbra",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Tislelizumab-jsgr",
    "DosageFormName": "INJECTION, SOLUTION, CONCENTRATE",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20240314",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761232",
    "LabelerName": "BeOne Medicines USA, Inc.",
    "SubstanceName": "TISLELIZUMAB",
    "StrengthNumber": "10",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-12-16",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20240314",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}